| Symbol | PHIO |
|---|---|
| Name | PHIO PHARMACEUTICALS CORP. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 257 SIMARANO DRIVE,SUITE 101, MARLBOROUGH, Massachusetts, 01752, United States |
| Telephone | +1 508 767-3861 |
| Fax | — |
| — | |
| Website | https://www.phiopharma.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001533040 |
| Description | Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The companys pipeline products include PH-762, PH-804, PH-790, and others. Additional info from NASDAQ: |
Director Bitterman Robert J 🟢 acquired 10.0K shares of Phio Pharmaceuticals Corp. (PHIO) at $0.99 Transaction Date: Jun 26, 2026 | Filing ID: 005164
Read morePhio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Read morePhio Pharmaceuticals Announces "How siRNA Therapy can Change the Course of Cancer Treatment" in a Fireside Chat with Force Family Office on Monday, June 29, 2026
Read morePhio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762
Read morePhio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
Read morePhio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Read morePhio Pharmaceuticals Announces "Innovations in Skin Cancer Treatment and Prevention" in a Fireside Chat with Force Family Office on Tuesday, May 19, 2026
Read more(30% Negative) PHIO PHARMACEUTICALS CORP. (PHIO) Reports Q2 2026 Financial Results
Read morePhio Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update
Read morePhio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Read more